Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Disease mechanisms in MS: Cell adhesion molecule MCAM on pathogenic T cells-a green light for CNS entry in multiple sclerosis.
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men.
Brain atrophy and lesion load predict long term disability in multiple sclerosis.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.
Retrograde retinal damage after acute optic tract lesion in MS.
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes.
Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.
microRNAs: A connection between cholesterol metabolism and neurodegeneration.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination During Proteasomal Degradation.
Acupuncture and multiple sclerosis: a review of the evidence.
Experimental Autoimmune Encephalomyelitis in Marmosets.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
Treating prolactinoma can prevent autoimmune diseases.
Plant sterols: Friend or foe in CNS disorders?
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
The rehabilitation of the multiple sclerosis patient.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis.
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.

Pages